67024-1-Ig

antibody from Proteintech Group

Targeting: RAD51 BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA

Provider product page for 67024-1-Ig

Western blot

ELISA

Antibody data

Antibody Data
Antigen structure
References [19]
Comments [0]
Validations [0]

Submit

Product number: 67024-1-Ig - Provider product page
Provider: Proteintech Group
Product name: RAD51 antibody
Antibody type: Monoclonal
Description: RAD51 antibody (Cat. #67024-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: WB, ELISA.
Reactivity: Human, Mouse, Rat
Host: Mouse
Conjugate: Unconjugated
Isotype: IgG
Antibody clone number: 4A12B8
Vial size: 20ul, 150ul

RAD51 protein structure - 67024-1-Ig shown in red.

Submitted references PGK1/PHGDH axis drives radioresistance in glioblastoma stem cells.

Cheng Z, Ding F, Yin J, Wang Y, Gao Y, Ge X, Zhang J, Wang X, Zhao M, Zhao N, Shu C, Wang X, Qian X, Qian C, Ji J, You Y, Shi Z
Cancer letters 2026 Jul 10;650:218517

Low-dose X-ray-activated radiodynamic therapy via a lutetium-coordinated nanoplatform synergizing PARP inhibition and ferroptosis.

Song W, Zhao C, Mai Y, Zhang G, Kang W, Zheng X, Yuan Q, Chen Z, Zhong C, Tang J, Fu D, Zhai T, Ling K, Jiang H
Journal of nanobiotechnology 2026 Jan 16;24(1):148

Targeted suppression of DNA polymerase θ enhances calcium flux and triggers intrinsic apoptosis in gastric cancer.

Wang Y, Nan J, Hu Y, Meng Y, Wang B, Ye Z, Chu X, Jing J, Cheng X
Cancer cell international 2026 Feb 5;26(1)

Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: integrated network pharmacology, molecular dynamics simulation, and experimental validation.

Yu Z, Peng W, Li M, Li F, Zhang T, Nong Y, Liu C, Liu W, Ding H, Lv X, Wang J, Zhang X, Liu F, Wu H
International journal of surgery (London, England) 2026 Feb 5;112(4):9404-26

POLA1 mediates hexavalent chromium-induced ovarian tumor progression through replication stress and DNA damage response.

Guo H, Sun Z, Li M, Yao S, Yan L
Toxicology 2026 Aug;524:154465

KLF11 interacts with MDM2 to stabilize E2F1 and promotes DNA damage repair to induce radioresistance in esophageal cancer cells.

Xia Y, Wang J, Zhao D, Li Y, Li S, Li M, Dong R, Wang L
Pathology, research and practice 2026 Apr;280:156375

Phase separation of ERCC6L2-CtIP regulates the extent of DNA end resection.

Yin Y, Lin J, Cai X, Nie R, Lin J, Li S, Xiang Z, Ling Y, Zhang Y, Zhou J, Chen J, Lin W, Duan J, Zheng X, Xie D, Cai M
Nature cell biology 2025 Oct;27(10):1771-1784

Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.

Flörkemeier I, Hotze HL, Heyne AL, Hildebrandt J, Weimer JP, Hedemann N, Rogmans C, Holthaus D, Siebert FA, Hirt M, Polten R, Morgan M, Klapdor R, Schambach A, Dempfle A, Maass N, van Mackelenbergh MT, Clement B, Bauerschlag DO
International journal of molecular sciences 2025 Mar 21;26(7)

Nuclear-Localized BCKDK Facilitates Homologous Recombination Repair to Support Breast Cancer Progression and Therapy Resistance.

Liu H, Feng J, Pan T, Zhang P, Ye L, Jiang Z, Zhou Z, Mao Q, Li J, Yang X, Gao P, Huang D, Zhang H
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jun;12(22):e2416590

2β-methoxy-2-deethoxyphantomolin synergistically enhances epirubicin effect against triple-negative breast cancer via targeted inhibition of AKT and HR pathways.

Gu J, You R, Zhao N, Xu X, Zhou J, Zhang X, Zhang Q, Jiang J, Jiang Y, Wen S
Bioorganic chemistry 2025 Jun 15;160:108453

Multi-omics integration of TPX2 in prognostic prediction in resectable hepatocellular carcinoma.

Zhao H, Duan W, Qu T, Tong X, Zhan C, Zhang Y
Discover oncology 2025 Jun 12;16(1):1077

Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair.

Li X, Zhang C, Mei Y, Zhong W, Fan W, Liu L, Feng Z, Bai X, Liu C, Xiao M, He W, Lin T, Gou X
Signal transduction and targeted therapy 2025 Jul 10;10(1):214

Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.

Wei Y, Wang P, Zhao J, Fan X, Jiang J, Mu X, Wang Y, Yang A, Zhang R, Hu S, Guo Z
Cell death & disease 2025 Jan 26;16(1):47

Acetyl alkannin, a Shikonin monomer, inhibits the ATM/DDR pathway by targeting ATM and sensitizes cisplatin in solid tumors.

Xu X, Gu J, Yang P, Huang L, Zhao N, Tang J, Liang Z, Li Q, Wen S, Jiang J, Zhang Q
Chemico-biological interactions 2025 Aug 25;417:111559

Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1/FTL/POLQ/RAD51 axis.

Zhang Q, Chen C, Zou X, Wu W, Di Y, Li N, Fu A
Cell death & disease 2024 May 13;15(5):329

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression.

Sun Z, Li L, Zhai B, Hu M, Huang L, Huang S, Ye L, Kong X, Xu J, Bai J, Yan J, Zhou Q, Hu Z, Zhang Y, Jiang Y, Zhang Y, Qiao Z, Zou Y, Xu Y, Zhu Q
Journal of medicinal chemistry 2024 Mar 28;67(6):4916-4935

NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.

Yu M, Ni M, Xu F, Liu C, Chen L, Li J, Xia S, Diao Y, Chen J, Zhu J, Wu X, Tang M, Li J, Ke G
Molecular cancer 2024 Jul 5;23(1):139

Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer.

Flörkemeier I, Hillmann JS, Weimer JP, Hildebrandt J, Hedemann N, Rogmans C, Dempfle A, Arnold N, Clement B, Bauerschlag DO
International journal of molecular sciences 2022 Sep 10;23(18)

Minimizing adverse effects of Cerenkov radiation induced photodynamic therapy with transformable photosensitizer-loaded nanovesicles.

Qian R, Wang K, Guo Y, Li H, Zhu Z, Huang X, Gong C, Gao Y, Guo R, Yang B, Wang C, Jiang D, Lan X, An R, Gao Z
Journal of nanobiotechnology 2022 Apr 27;20(1):203

No comments: Submit comment

No validations: Submit validation data